NISSY PHILIP: Open Payments
NPI 1477922441 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,942 in 79 payments from 19 companies in 2025. Trend: 2023 $1,082 · 2024 $1,556 · 2025 $1,942
Food & beverage: $1,942
| Company | Payments | Amount |
|---|---|---|
| Travere Therapeutics, Inc. | 11 | $311 |
| Calliditas Therapeutics US Inc. | 9 | $293 |
| AstraZeneca Pharmaceuticals LP | 9 | $207 |
| SHIELD THERAPEUTICS INC | 4 | $199 |
| Amgen Inc. | 10 | $141 |
| Novo Nordisk Inc | 6 | $129 |
| Pharmacosmos Therapeutics Inc. | 4 | $90 |
| Ardelyx, Inc. | 4 | $77 |
| Otsuka America Pharmaceutical, Inc. | 3 | $77 |
| GlaxoSmithKline, LLC. | 4 | $76 |
Products named: TARPEYO, FARXIGA, ACCRUFER, MONOFERRIC, KRYSTEXXA, IBSRELA, Ozempic, ULTOMIRIS.
Industry payments across OK — which companies pay providers there.
